141 studies found for:    Ataxia
Show Display Options
Rank Status Study
21 Completed Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
Condition: Ataxia Telangiectasia (AT)
Intervention: Drug: Conjugated pneumococcal vaccine (Prevenar)
22 Completed Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias
Conditions: Congenital Cerebellar Ataxias;   Early-onset Cerebellar Ataxias
Intervention: Genetic: blood sample
23 Completed Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
24 Completed
Has Results
Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: EGb 761 120 mg;   Drug: Placebo
25 Terminated Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: varenicline;   Drug: placebo
26 Completed Coenzyme Q10 in Adult-Onset Ataxia
Condition: Sporadic Ataxia
Interventions: Drug: Placebo (sugar pill);   Drug: Coenzyme Q10
27 Recruiting Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Condition: Friedreich's Ataxia
Intervention:
28 Unknown  The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally
Condition: Ataxia Telangiectasia
Intervention:
29 Completed Lithium Treatment for Patients With Spinocerebellar Ataxia Type I
Condition: Spinocerebellar Ataxia Type I
Intervention: Drug: Lithium Carbonate
30 Completed Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
Condition: SPINOCEREBELLAR ATAXIA 2
Intervention: Drug: LITHIUM CARBONATE
31 Unknown  Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Conditions: Ataxia Telangiectasia;   Growth Failure
Intervention: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate
32 Completed Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Biological: IVIG
33 Unknown  Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients
Condition: Ataxia Telangiectasia
Interventions: Biological: Prevenar® (7-valent pneumococcal conjugate vaccine);   Biological: Pneumovax® (pneumococcal polysaccharide vaccine)
34 Completed Safety Study of Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
35 Not yet recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: RTA 408 Capsules, 2.5 mg;   Drug: RTA 408 Capsules, 5 mg;   Drug: RTA 408 Capsules, 10 mg;   Drug: Placebo
36 Completed Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling
Condition: Friedreich Ataxia
Intervention:
37 Completed Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
Conditions: Spinocerebellar Ataxia Type 3;   Machado Joseph Disease
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
38 Completed Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
Condition: Spinocerebellar Ataxia
Intervention:
39 Recruiting An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: Acetyl-L-Carnitine
40 Completed The Effect of Whole Body Vibration Training on Neuromuscular Property in Individuals With Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Other: Whole body vibration training

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years